CUNNINGHAM PANEL
THE CUNNINGHAM PANEL™ - Autoantibody testing for neuropsychiatric symptoms. Read more
Please contact us at info@redlabs.be for further details and/or to order the kit.
The Cunningham Panel™ helps clinicians identify whether a patient’s neurologic and/or psychiatric symptoms may be due to an infection-triggered basal ganglia encephalitis (BGE), which includes autoimmune neuropsychiatric syndromes such as PANS/PANDAS. Symptoms of BGE can mimic various mental illnesses.
This panel is composed of 5 tests: Anti-Dopamine D1 Receptor, Anti-Dopamine D2L Receptor, Anti-Lysoganglioside-GM1, Anti-Tubulin and Calcium/calmodulin-dependent protein kinase II (CaMKII). First four of the tests measure the levels of circulating autoantibodies in serum that are directed against and bind to, or block specific neuronal targets in the brain. Each of these autoantibody targets (Dopamine D1 and D2L receptors,
Please contact us at info@redlabs.be for further details and/or to order the kit.
Please kindly note that for all the tests that are done in our partner labs in the USA, a full prepayment must be received before your sample is sent for testing.
Partner labs demand a full prepayment before the sample can begin to travel. Thank you for your understanding and collaboration.
It will take approx. 4 weeks to get the results from all tests, except for MSA (6 weeks) and CD56 and CD57 (48 -72 hours).
feedback Report comment